FDA publishes two 510(k) guidances on ultrasound and related types of devices.
Intarcia Therapeutics accepts an FDA proposal to allow an advisory committee to review and address a 2021 CDER decision not to approve the companys Ty...
Merck says a study of its Covid-19 drug Lagevrio (molnupiravir) did not meet the primary endpoint a statistically significant risk reduction in those...
HHS publishes its semiannual regulatory agenda that outlines numerous FDA rulemaking activities under development, including a final rule on DTC Rx dr...
FDA approves Chiesis Lamzede to treat some manifestations of alpha-mannosidosis in adults and children.
Federal Register notice: FDA withdraws a Miles Laboratories ANDA for alcohol and dextrose injection, 5 mL/100 mL because the agency has scientific dat...
FDA publishes a draft guidance with information on requesting and conducting product-specific guidance meetings between FDA and ANDA applicants.
FDA commissioner Robert Califf announces a project to explore ways the agency can respond to and counter misleading health information in a variety of...